GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
Research Highlights:
Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer…
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods | Cardiovascular Diabetology
Study design We collected individual patient-level data from the LEADER [7] and SUSTAIN-6 [8] CVOTs as well as…